Publicaciones en las que colabora con Martha Kestler Hernández (11)

2022

  1. Comorbidity and Prognosis in Octogenarians with Infective Endocarditis

    Journal of Clinical Medicine, Vol. 11, Núm. 13

2021

  1. Clinical factors associated with reinfection versus relapse in infective endocarditis: Prospective cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-12

  2. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

  3. Prevention, diagnosis and management of post‐surgical mediastinitis in adults consensus guidelines of the spanish society of cardiovascular infections (Seicav), the spanish society of thoracic and cardiovascular surgery (sectcv) and the biomedical research centre network for respiratory diseases (ciberes)

    Journal of Clinical Medicine, Vol. 10, Núm. 23

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

2019

  1. The “Endocarditis Team” of the Spanish Society of Cardiovascular Infections (SEICAV) reached 4500 cases collected prospectively

    Cirugia Cardiovascular, Vol. 26, Núm. 5, pp. 215-216

2017

  1. Endocarditis caused by anaerobic bacteria

    Anaerobe, Vol. 47, pp. 33-38

2016

  1. 2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adult

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 4, pp. 230-238

  2. 2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adults

    Cirugia Cardiovascular, Vol. 23, Núm. 4, pp. 192-198

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18